Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The British Journal of Dermatology
|
August 10, 2019
Low-fluence fractional CO<sub>2</sub> laser in the treatment of idiopathic guttate hypomelanosis: a pilot study
S H Eun, H S Kwon, H J Ju, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 4, 2009
Characteristic features of unruptured intracranial aneurysms: predictive risk factors for aneurysm rupture
S-H You, D-S Kong, J-S Kim, et al.
International Endodontic Journal
|
May 28, 2014
Nitric oxide induces apoptosis in human gingival fibroblast through mitochondria-dependent pathway and JNK activation
M-W Baek, K-J Seong, Y-J Jeong, et al.
Clinical and Experimental Dermatology
|
April 25, 2013
Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea
Ji Hyun Lee, Ji Hae Lee, D S Yoo, et al.
Human Pathology
|
June 30, 2001
Pathogenic significance of neuronal migration disorders in temporal lobe epilepsy
M C Lee, G M Kim, Y J Woo, et al.
Journal of Neurology
|
May 14, 1999
Frequency of spinocerebellar ataxia types 1,2,3,6,7 and dentatorubral pallidoluysian atrophy mutations in Korean patients with spinocerebellar ataxia
D K Jin, M R Oh, S M Song, et al.
ESMO Open
|
March 12, 2026
A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer
G M Kim, M H Kim, H S Park, et al.
European Journal of Neurology
|
February 18, 2020
Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke
J-M Kim, K-Y Park, I-W Yu, et al.
ESMO Open
|
June 10, 2025
Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer
S Nag, I Ray Coquard, S Gupta, et al.
ESMO Open
|
September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
S-A Im, K Park, J Koh, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The British Journal of Dermatology
|
August 10, 2019
Low-fluence fractional CO<sub>2</sub> laser in the treatment of idiopathic guttate hypomelanosis: a pilot study
S H Eun, H S Kwon, H J Ju, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 4, 2009
Characteristic features of unruptured intracranial aneurysms: predictive risk factors for aneurysm rupture
S-H You, D-S Kong, J-S Kim, et al.
International Endodontic Journal
|
May 28, 2014
Nitric oxide induces apoptosis in human gingival fibroblast through mitochondria-dependent pathway and JNK activation
M-W Baek, K-J Seong, Y-J Jeong, et al.
Clinical and Experimental Dermatology
|
April 25, 2013
Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea
Ji Hyun Lee, Ji Hae Lee, D S Yoo, et al.
Human Pathology
|
June 30, 2001
Pathogenic significance of neuronal migration disorders in temporal lobe epilepsy
M C Lee, G M Kim, Y J Woo, et al.
Journal of Neurology
|
May 14, 1999
Frequency of spinocerebellar ataxia types 1,2,3,6,7 and dentatorubral pallidoluysian atrophy mutations in Korean patients with spinocerebellar ataxia
D K Jin, M R Oh, S M Song, et al.
ESMO Open
|
March 12, 2026
A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer
G M Kim, M H Kim, H S Park, et al.
European Journal of Neurology
|
February 18, 2020
Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke
J-M Kim, K-Y Park, I-W Yu, et al.
ESMO Open
|
June 10, 2025
Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer
S Nag, I Ray Coquard, S Gupta, et al.
ESMO Open
|
September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
S-A Im, K Park, J Koh, et al.
Page
of 6